Latest Industry Insights

In the heart of Cambridge, a quiet revolution is reshaping the way science startups scale: one built not only on breakthrough molecules and patents, but also on collaborative spaces, shared values and pragmatic support.

We spoke with Castle Bioscience's Dr. Rebecca Critchley-Thorne about AI-enabled spatial proteomics, TissueCypher’s impact on Barrett’s esophagus management and its broader potential for precision oncology.

Learn how scientists mapped the protein landscape of toxic epidermal necrolysis, a lethal skin disease, a lethal skin disease, by applying Deep Visual Proteomics, leading to the use of JAK inhibitors with life-saving results.

As global scientific and regulatory landscapes shift, companies across the life sciences sector are under growing pressure to adapt. Hear how Phenomenex are taking a proactive approach.

This article explores the unique characteristics and challenges of life sciences marketing, offering insights on how to achieve meaningful engagement with a highly specialized audience.

In this article, discover how the FDA and NIH are replacing animal testing with human models, such as organoids, featuring expert insights on safer, faster and ethical drug development.

At the 2025 American Society for Mass Spectrometry (ASMS) conference, experts shared how the industry is embracing sustainable practices while driving innovation and productivity.

To explore AI's growing impact, Technology Networks asked experts at the 2025 ASMS conference a single question: How can AI support analytical science workflows, both today and in the years ahead?

Discover how VR labs with AI assistants are transforming global research, enabling immersive training, real-time data sharing and equitable access.

In this article, the Technology Networks team chatted with various experts at ASMS 2025 about what they believe will be important technological advances in mass spectrometry.